{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:02:33Z","timestamp":1785888153516,"version":"3.56.0"},"reference-count":116,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Riluzole is a glutamatergic modulator that has recently shown potential for neuroprotection after spinal cord injury (SCI). While the effects of riluzole are extensively documented in animal models of SCI, there remains heterogeneity in findings. Moreover, there is a paucity of data on the pharmacology of riluzole and its effects in humans. For the present study, the authors systematically reviewed the literature to provide a comprehensive understanding of the effects of riluzole in SCI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The PubMed database was queried from 1996 to September 2018 to identify animal studies and clinical trials involving riluzole administration for SCI. Once articles were identified, they were processed for year of publication, study design, subject type, injury model, number of subjects in experimental and control groups, dose, timing\/route of administration, and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 37 studies were included in this study. Three placebo-controlled clinical trials were included with a total of 73 patients with a mean age of 39.1 years (range 18\u201370 years). For the clinical trials included within this study, the American Spinal Injury Association Impairment Scale distributions for SCI were 42.6% grade A, 25% grade B, 26.6% grade C, and 6.2% grade D. Key findings from studies in humans included decreased nociception, improved motor function, and attenuated spastic reflexes. Twenty-six animal studies (24 in vivo, 1 in vitro, and 1 including both in vivo and in vitro) were included. A total of 520 animals\/in vitro specimens were exposed to riluzole and 515 animals\/in vitro specimens underwent other treatment for comparison. The average dose of riluzole for intraperitoneal, in vivo studies was 6.5 mg\/kg (range 1\u201310 mg\/kg). Key findings from animal studies included behavioral improvement, histopathological tissue sparing, and modified electrophysiology after SCI. Eight studies examined the pharmacology of riluzole in SCI. Key findings from pharmacological studies included riluzole dose-dependent effects on glutamate uptake and its modified bioavailability after SCI in both animal and clinical models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>SCI has many negative sequelae requiring neuroprotective intervention. While still relatively new in its applications for SCI, both animal and human studies demonstrate riluzole to be a promising pharmacological intervention to attenuate the devastating effects of this condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2019.1.focus18596","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T02:09:41Z","timestamp":1551838181000},"page":"E6","source":"Crossref","is-referenced-by-count":39,"title":["Efficacy of riluzole in the treatment of spinal cord injury: a systematic review of the literature"],"prefix":"10.3171","volume":"46","author":[{"given":"Shanmukha","family":"Srinivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvin R.","family":"Wali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"J Clin Neurosci","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jocn.2006.03.023","article-title":"Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury","volume":"14","author":"Ates O","year":"2007","unstructured":"Ates O, Cayli SR, Gurses I, Turkoz Y, Tarim O, Cakir CO, : Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury. J Clin Neurosci 14:658\u2013665, 200710.1016\/j.jocn.2006.03.02317532502"},{"key":"b2","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0006-8993(00)02430-6","article-title":"Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes","volume":"871","author":"Azbill RD","year":"2000","unstructured":"Azbill RD, Mu X, Springer JE: Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res 871:175\u2013180, 20001089928410.1016\/S0006-8993(00)02430-6"},{"key":"b3","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0006-8993(94)01410-J","article-title":"Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat","volume":"672","author":"Bartholdi D","year":"1995","unstructured":"Bartholdi D, Schwab ME: Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res 672:177\u2013186, 199510.1016\/0006-8993(94)01410-J7749740"},{"key":"b4","series-title":"CNS Neurosci Ther","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1755-5949.2009.00116.x","article-title":"A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?","volume":"17","author":"Bellingham MC","year":"2011","unstructured":"Bellingham MC: A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci Ther 17:4\u201331, 201110.1111\/j.1755-5949.2009.00116.x20236142"},{"key":"b5","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nm.4061","article-title":"Cleavage of Na+ channels by calpain increases persistent Na+ current and promotes spasticity after spinal cord injury","volume":"22","author":"Brocard C","year":"2016","unstructured":"Brocard C, Plantier V, Boulenguez P, Liabeuf S, Bouhadfane M, Viallat-Lieutaud A, : Cleavage of Na+ channels by calpain increases persistent Na+ current and promotes spasticity after spinal cord injury. Nat Med 22:404\u2013411, 201610.1038\/nm.406126974309"},{"key":"b6","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e247","DOI":"10.1016\/j.wneu.2018.02.171","article-title":"Effect of riluzole on spinal cord regeneration with hemisection method before injury","volume":"114","author":"Caglar YS","year":"2018","unstructured":"Caglar YS, Demirel A, Dogan I, Huseynov R, Eroglu U, Ozgural O, : Effect of riluzole on spinal cord regeneration with hemisection method before injury. World Neurosurg 114:e247\u2013e253, 201810.1016\/j.wneu.2018.02.171"},{"key":"b7","series-title":"Ulus Travma Acil Cerrahi Derg","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.wneu.2018.02.171","article-title":"Combined and individual use of pancaspase inhibitor Q-VD-OPh and NMDA receptor antagonist riluzole in experimental spinal cord injury","volume":"23","author":"Can H","year":"2017","unstructured":"Can H, Aydoseli A, G\u00f6mleksiz C, G\u00f6ker B, Altunrende ME, Dolgun M, : Combined and individual use of pancaspase inhibitor Q-VD-OPh and NMDA receptor antagonist riluzole in experimental spinal cord injury. Ulus Travma Acil Cerrahi Derg 23:452\u2013458, 20172911565810.1016\/j.wneu.2018.02.171"},{"key":"b8","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.apmr.2004.03.016","article-title":"Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis","volume":"85","author":"Cardenas DD","year":"2004","unstructured":"Cardenas DD, Hoffman JM, Kirshblum S, McKinley W: Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Arch Phys Med Rehabil 85:1757\u20131763, 20041552097010.1016\/j.apmr.2004.03.016"},{"key":"b9","series-title":"Curr Med Chem","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.2174\/092986710791163939","article-title":"Riluzole, neuroprotection and amyotrophic lateral sclerosis","volume":"17","author":"Cheah BC","unstructured":"Cheah BC, Vucic S, Krishnan AV, Kiernan MC: Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 17:1942\u2013199, 201010.2174\/09298671079116393920377511"},{"issue":"1 Suppl","key":"b10","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3171\/2012.5.AOSPINE12112","article-title":"Pharmacology of riluzole in acute spinal cord injury","volume":"17","author":"Chow DS","year":"2012","unstructured":"Chow DS, Teng Y, Toups EG, Aarabi B, Harrop JS, Shaffrey CI, : Pharmacology of riluzole in acute spinal cord injury. J Neurosurg Spine 17 (1 Suppl):129\u2013140, 20122298537910.3171\/2012.5.AOSPINE12112"},{"key":"b11","series-title":"Neuroscientist","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1073858412444932","article-title":"Riluzole: what it does to spinal and brainstem neurons and how it does it","volume":"19","author":"Cifra A","year":"2013","unstructured":"Cifra A, Mazzone GL, Nistri A: Riluzole: what it does to spinal and brainstem neurons and how it does it. Neuroscientist 19:137\u2013144, 201310.1177\/107385841244493222596264"},{"key":"b12","series-title":"Nat Rev Neurosci","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrn3053","article-title":"Repertoire of microglial and macrophage responses after spinal cord injury","volume":"12","author":"David S","year":"2011","unstructured":"David S, Kroner A: Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12:388\u2013399, 201110.1038\/nrn305321673720"},{"key":"b13","series-title":"Top Spinal Cord Inj Rehabil","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1310\/sci1604-1","article-title":"Costs of care following spinal cord injury","volume":"16","author":"DeVivo MJ","year":"2011","unstructured":"DeVivo MJ, Chen Y, Mennemeyer ST, Deutsch A: Costs of care following spinal cord injury. Top Spinal Cord Inj Rehabil 16:1\u20139, 201110.1310\/sci1604-1"},{"issue":"6 Suppl 4","key":"b14","series-title":"Neurology","first-page":"S233","article-title":"The pharmacology and mechanism of action of riluzole","volume":"47","author":"Doble A","year":"1996","unstructured":"Doble A: The pharmacology and mechanism of action of riluzole. Neurology 47 (6 Suppl 4):S233\u2013S241, 1996"},{"key":"b15","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/neu.2012.2587","article-title":"The dual cyclooxygenase\/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord","volume":"30","author":"Dulin JN","year":"2013","unstructured":"Dulin JN, Moore ML, Grill RJ: The dual cyclooxygenase\/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord. J Neurotrauma 30:211\u2013226, 201310.1089\/neu.2012.258722947335"},{"key":"b16","series-title":"Clin Neuropharmacol","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00002826-200109000-00002","article-title":"Acute spinal cord injury, part I: pathophysiologic mechanisms","volume":"24","author":"Dumont RJ","year":"2001","unstructured":"Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, : Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 24:254\u2013264, 20011158611010.1097\/00002826-200109000-00002"},{"key":"b17","series-title":"J Clin Neurosci","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jocn.2017.08.032","article-title":"Riluzole-induced recurrent pancreatitis","volume":"45","author":"Falc\u00e3o de Campos C","year":"2017","unstructured":"Falc\u00e3o de Campos C, de Carvalho M: Riluzole-induced recurrent pancreatitis. J Clin Neurosci 45:153\u2013154, 201710.1016\/j.jocn.2017.08.032"},{"key":"b18","series-title":"Spinal Cord","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sc.2015.95","article-title":"Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial","volume":"54","author":"Fehlings MG","year":"2016","unstructured":"Fehlings MG, Nakashima H, Nagoshi N, Chow DSL, Grossman RG, Kopjar B: Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial. Spinal Cord 54:8\u201315, 201610.1038\/sc.2015.9526099215"},{"issue":"1 Suppl","key":"b19","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/2012.4.AOSPINE1259","article-title":"Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial","volume":"17","author":"Fehlings MG","year":"2012","unstructured":"Fehlings MG, Wilson JR, Frankowski RF, Toups EG, Aarabi B, Harrop JS, : Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial. J Neurosurg Spine 17 (1 Suppl):151\u2013156, 20122298538110.3171\/2012.4.AOSPINE1259"},{"key":"b20","series-title":"J Spinal Cord Med","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/10790268.2007.11754581","article-title":"Health care costs for patients with chronic spinal cord injury in the Veterans Health Administration","volume":"30","author":"French DD","year":"2007","unstructured":"French DD, Campbell RR, Sabharwal S, Nelson AL, Palacios PA, Gavin-Dreschnack D: Health care costs for patients with chronic spinal cord injury in the Veterans Health Administration. J Spinal Cord Med 30:477\u2013481, 20071809256410.1080\/10790268.2007.11754581"},{"key":"b21","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1089\/neu.2016.4754","article-title":"Delayed spinal cord-brachial plexus reconnection after C7 ventral root avulsion: the effect of reinnervating motoneurons rescued by riluzole treatment","volume":"34","author":"Gloviczki B","year":"2017","unstructured":"Gloviczki B, T\u00f6r\u00f6k DG, M\u00e1rton G, G\u00e1l L, Bodzay T, Pint\u00e9r S, : Delayed spinal cord-brachial plexus reconnection after C7 ventral root avulsion: the effect of reinnervating motoneurons rescued by riluzole treatment. J Neurotrauma 34:2364\u20132374, 20172865748710.1089\/neu.2016.4754"},{"key":"b22","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/neu.2013.2969","article-title":"A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury","volume":"31","author":"Grossman RG","year":"2014","unstructured":"Grossman RG, Fehlings MG, Frankowski RF, Burau KD, Chow DS, Tator C, : A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J Neurotrauma 31:239\u2013255, 201410.1089\/neu.2013.296923859435"},{"issue":"Pt B","key":"b23","series-title":"Int J Dev Neurosci","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijdevneu.2015.08.007","article-title":"Evaluation of the effects of riluzole on adult spinal cord-derived neural stem\/progenitor cells in vitro and in vivo","volume":"47","author":"Hachem LD","year":"2015","unstructured":"Hachem LD, Mothe AJ, Tator CH: Evaluation of the effects of riluzole on adult spinal cord-derived neural stem\/progenitor cells in vitro and in vivo. Int J Dev Neurosci 47 (Pt B):140\u2013146, 20152639095410.1016\/j.ijdevneu.2015.08.007"},{"key":"b24","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/neu.2010.1539","article-title":"Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain","volume":"28","author":"Hama A","year":"2011","unstructured":"Hama A, Sagen J: Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain. J Neurotrauma 28:127\u2013134, 201110.1089\/neu.2010.153920954888"},{"key":"b25","series-title":"J Neurophysiol","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1152\/jn.00335.2005","article-title":"Persistent sodium currents and repetitive firing in motoneurons of the sacrocaudal spinal cord of adult rats","volume":"96","author":"Harvey PJ","year":"2006","unstructured":"Harvey PJ, Li Y, Li X, Bennett DJ: Persistent sodium currents and repetitive firing in motoneurons of the sacrocaudal spinal cord of adult rats. J Neurophysiol 96:1141\u20131157, 20061628220610.1152\/jn.00335.2005"},{"key":"b26","series-title":"Degener Neurol Neuromuscul Dis","first-page":"61","article-title":"Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis","volume":"7","author":"Hinchcliffe M","year":"2017","unstructured":"Hinchcliffe M, Smith A: Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis. Degener Neurol Neuromuscul Dis 7:61\u201370, 201730050378"},{"key":"b27","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1089\/neu.2015.3892","article-title":"A direct comparison of three clinically relevant treatments in a rat model of cervical spinal cord injury","volume":"32","author":"Hosier H","year":"2015","unstructured":"Hosier H, Peterson D, Tsymbalyuk O, Keledjian K, Smith BR, Ivanova S, : A direct comparison of three clinically relevant treatments in a rat model of cervical spinal cord injury. J Neurotrauma 32:1633\u20131644, 201510.1089\/neu.2015.3892"},{"key":"b28","series-title":"Spinal Cord","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/sj.sc.3101670","article-title":"Neuropathology: the foundation for new treatments in spinal cord injury","volume":"42","author":"Kakulas BA","year":"2004","unstructured":"Kakulas BA: Neuropathology: the foundation for new treatments in spinal cord injury. Spinal Cord 42:549\u2013563, 20041534613110.1038\/sj.sc.3101670"},{"key":"b29","series-title":"FASEB J","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1096\/fj.02-0143fje","article-title":"Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus","volume":"16","author":"Katoh-Semba R","year":"2002","unstructured":"Katoh-Semba R, Asano T, Ueda H, Morishita R, Takeuchi IK, Inaguma Y, : Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J 16:1328\u20131330, 200210.1096\/fj.02-0143fje12154010"},{"key":"b30","series-title":"Neurosci Lett","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neulet.2009.03.016","article-title":"Effectiveness of riluzole in suppressing spasticity in the spinal cord injured rat","volume":"455","author":"Kitzman PH","year":"2009","unstructured":"Kitzman PH: Effectiveness of riluzole in suppressing spasticity in the spinal cord injured rat. Neurosci Lett 455:150\u2013153, 200910.1016\/j.neulet.2009.03.01619368865"},{"key":"b31","series-title":"J Vasc Surg","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1067\/mva.2000.105960","article-title":"Prevention of ischemic spinal cord injury: comparative effects of magnesium sulfate and riluzole","volume":"32","author":"Lang-Lazdunski L","year":"2000","unstructured":"Lang-Lazdunski L, Heurteaux C, Dupont H, Widmann C, Lazdunski M: Prevention of ischemic spinal cord injury: comparative effects of magnesium sulfate and riluzole. J Vasc Surg 32:179\u2013189, 20001087622110.1067\/mva.2000.105960"},{"key":"b32","series-title":"Eur J Cardiothorac Surg","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1010-7940(00)00430-9","article-title":"Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole","volume":"18","author":"Lang-Lazdunski L","year":"2000","unstructured":"Lang-Lazdunski L, Heurteaux C, Mignon A, Mantz J, Widmann C, Desmonts J, : Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole. Eur J Cardiothorac Surg 18:174\u2013181, 200010.1016\/S1010-7940(00)00430-910925226"},{"key":"b33","series-title":"Anesthesiology","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00000542-200011000-00025","article-title":"Neuroprotective effects of riluzole and ketamine during transient spinal cord ischemia in the rabbit","volume":"93","author":"Lips J","year":"2000","unstructured":"Lips J, de Haan P, Bodewits P, Vanicky I, Dzoljic M, Jacobs MJ, : Neuroprotective effects of riluzole and ketamine during transient spinal cord ischemia in the rabbit. Anesthesiology 93:1303\u20131311, 200010.1097\/00000542-200011000-0002511046220"},{"key":"b34","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.spinee.2017.10.067","article-title":"Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats","volume":"18","author":"Martins BC","year":"2018","unstructured":"Martins BC, Torres BBJ, de Oliveira KM, Lavor MS, Os\u00f3rio CM, Fukushima FB, : Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats. Spine J 18:532\u2013539, 20182915525410.1016\/j.spinee.2017.10.067"},{"key":"b35","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainres.2005.01.024","article-title":"The effect of glutamate receptor blockers on glutamate release following spinal cord injury. Lack of evidence for an ongoing feedback cascade of damage \u2192 glutamate release \u2192 damage \u2192 glutamate release \u2192 etc","volume":"1038","author":"McAdoo DJ","year":"2005","unstructured":"McAdoo DJ, Hughes MG, Nie L, Shah B, Clifton C, Fullwood S, : The effect of glutamate receptor blockers on glutamate release following spinal cord injury. Lack of evidence for an ongoing feedback cascade of damage \u2192 glutamate release \u2192 damage \u2192 glutamate release \u2192 etc. Brain Res 1038:92\u201399, 200510.1016\/j.brainres.2005.01.02415748877"},{"key":"b36","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0140-6736(02)07603-1","article-title":"Spinal-cord injury","volume":"359","author":"McDonald JW","year":"2002","unstructured":"McDonald JW, Sadowsky C: Spinal-cord injury. Lancet 359:417\u2013425, 20021184453210.1016\/S0140-6736(02)07603-1"},{"key":"b37","series-title":"Asian J Neurosurg","first-page":"656","article-title":"Riluzole can improve sensory and motor function in patients with acute spinal cord injury","volume":"13","author":"Meshkini A","year":"2018","unstructured":"Meshkini A, Salehpour F, Aghazadeh J, Mirzaei F, Naseri Alavi SA: Riluzole can improve sensory and motor function in patients with acute spinal cord injury. Asian J Neurosurg 13:656\u2013659, 201830283521"},{"key":"b38","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1089\/neu.2000.17.773","article-title":"Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury","volume":"17","author":"Mu X","year":"2000","unstructured":"Mu X, Azbill RD, Springer JE: Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury. J Neurotrauma 17:773\u2013780, 20001101181710.1089\/neu.2000.17.773"},{"key":"b39","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0006-8993(00)02402-1","article-title":"Riluzole improves measures of oxidative stress following traumatic spinal cord injury","volume":"870","author":"Mu X","year":"2000","unstructured":"Mu X, Azbill RD, Springer JE: Riluzole improves measures of oxidative stress following traumatic spinal cord injury. Brain Res 870:66\u201372, 200010.1016\/S0006-8993(00)02402-110869502"},{"key":"b40","series-title":"J Spinal Cord Med","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1179\/1079026812Z.00000000063","article-title":"Spinal cord injury facts and figures at a glance","volume":"35","author":"National Spinal Cord Injury Statistical Center","year":"2012","unstructured":"National Spinal Cord Injury Statistical Center: Spinal cord injury facts and figures at a glance. J Spinal Cord Med 35:197\u2013198, 201210.1179\/1079026812Z.00000000063"},{"key":"b41","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuroscience.2006.09.046","article-title":"Delayed riluzole treatment is able to rescue injured rat spinal motoneurons","volume":"144","author":"N\u00f3gr\u00e1di A","year":"2007","unstructured":"N\u00f3gr\u00e1di A, Szab\u00f3 A, Pint\u00e9r S, Vrbov\u00e1 G: Delayed riluzole treatment is able to rescue injured rat spinal motoneurons. Neuroscience 144:431\u2013438, 20071708453710.1016\/j.neuroscience.2006.09.046"},{"key":"b42","series-title":"Neurobiol Dis","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1006\/nbdi.2000.0297","article-title":"A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C","volume":"7","author":"Noh KM","year":"2000","unstructured":"Noh KM, Hwang JY, Shin HC, Koh JY: A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiol Dis 7:375\u2013383, 20001096460810.1006\/nbdi.2000.0297"},{"key":"b43","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1089\/0897715041269641","article-title":"The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration","volume":"21","author":"Park E","year":"2004","unstructured":"Park E, Velumian AA, Fehlings MG: The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21:754\u2013774, 200410.1089\/089771504126964115253803"},{"key":"b44","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1089\/neu.2010.1445","article-title":"Increased survival and reinnervation of cervical motoneurons by riluzole after avulsion of the C7 ventral root","volume":"27","author":"Pint\u00e9r S","year":"2010","unstructured":"Pint\u00e9r S, Gloviczki B, Szab\u00f3 A, M\u00e1rton G, N\u00f3gr\u00e1di A: Increased survival and reinnervation of cervical motoneurons by riluzole after avulsion of the C7 ventral root. J Neurotrauma 27:2273\u20132282, 20102093969510.1089\/neu.2010.1445"},{"issue":"5","key":"b45","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/FOC.2008.25.11.E2","article-title":"Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon","volume":"25","author":"Rowland JW","year":"2008","unstructured":"Rowland JW, Hawryluk GW, Kwon B, Fehlings MG: Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 25(5):E2, 200810.3171\/FOC.2008.25.11.E218980476"},{"key":"b46","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.neuroscience.2012.06.064","article-title":"A study of the potential neuroprotective effect of riluzole on locomotor networks of the neonatal rat spinal cord in vitro damaged by excitotoxicity","volume":"222","author":"S\u00e1mano C","year":"2012","unstructured":"S\u00e1mano C, Nasrabady SE, Nistri A: A study of the potential neuroprotective effect of riluzole on locomotor networks of the neonatal rat spinal cord in vitro damaged by excitotoxicity. Neuroscience 222:356\u2013365, 201210.1016\/j.neuroscience.2012.06.06422771622"},{"key":"b47","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.expneurol.2015.09.011","article-title":"Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection","volume":"276","author":"Satkunendrarajah K","year":"2016","unstructured":"Satkunendrarajah K, Nassiri F, Karadimas SK, Lip A, Yao G, Fehlings MG: Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection. Exp Neurol 276:59\u201371, 20162639420210.1016\/j.expneurol.2015.09.011"},{"issue":"2 Suppl","key":"b48","series-title":"J Neurosurg","first-page":"245","article-title":"Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole","volume":"94","author":"Schwartz G","year":"2001","unstructured":"Schwartz G, Fehlings MG: Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole. J Neurosurg 94 (2 Suppl):245\u2013256, 200111302627"},{"key":"b49","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1089\/neu.2017.5494","article-title":"Prophylactic riluzole attenuates oxidative stress damage in spinal cord distraction","volume":"35","author":"Shimizu EN","year":"2018","unstructured":"Shimizu EN, Seifert JL, Johnson KJ, Romero-Ortega MI: Prophylactic riluzole attenuates oxidative stress damage in spinal cord distraction. J Neurotrauma 35:1319\u20131328, 20182929564710.1089\/neu.2017.5494"},{"key":"b50","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.expneurol.2011.11.044","article-title":"Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury","volume":"233","author":"Simard JM","year":"2012","unstructured":"Simard JM, Tsymbalyuk O, Keledjian K, Ivanov A, Ivanova S, Gerzanich V: Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury. Exp Neurol 233:566\u2013574, 201210.1016\/j.expneurol.2011.11.044"},{"key":"b51","series-title":"J Neurochem","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1046\/j.1471-4159.1997.69041592.x","article-title":"Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment","volume":"69","author":"Springer JE","year":"1997","unstructured":"Springer JE, Azbill RD, Kennedy SE, George J, Geddes JW: Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J Neurochem 69:1592\u20131600, 1997932628810.1046\/j.1471-4159.1997.69041592.x"},{"key":"b52","series-title":"Orthopedics","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3928\/01477447-20080301-39","article-title":"Hemodynamic management after spinal cord injury","volume":"31","author":"Stratman RC","year":"2008","unstructured":"Stratman RC, Wiesner AM, Smith KM, Cook AM: Hemodynamic management after spinal cord injury. Orthopedics 31:252\u2013255, 200810.3928\/01477447-20080301-3918351045"},{"key":"b53","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1523\/JNEUROSCI.23-07-02899.2003","article-title":"Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats","volume":"23","author":"Sung B","year":"2003","unstructured":"Sung B, Lim G, Mao J: Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 23:2899\u20132910, 200310.1523\/JNEUROSCI.23-07-02899.200312684477"},{"key":"b54","series-title":"J Neurophysiol","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1152\/jn.00570.2010","article-title":"Riluzole decreases flexion withdrawal reflex but not voluntary ankle torque in human chronic spinal cord injury","volume":"105","author":"Theiss RD","year":"2011","unstructured":"Theiss RD, Hornby TG, Rymer WZ, Schmit BD: Riluzole decreases flexion withdrawal reflex but not voluntary ankle torque in human chronic spinal cord injury. J Neurophysiol 105:2781\u20132790, 20112143028010.1152\/jn.00570.2010"},{"key":"b55","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.spinee.2016.04.013","article-title":"Combining neuroprotective agents: effect of riluzole and magnesium in a rat model of thoracic spinal cord injury","volume":"16","author":"Vasconcelos NL","year":"2016","unstructured":"Vasconcelos NL, Gomes ED, Oliveira EP, Silva CJ, Lima R, Sousa N, : Combining neuroprotective agents: effect of riluzole and magnesium in a rat model of thoracic spinal cord injury. Spine J 16:1015\u20131024, 201610.1016\/j.spinee.2016.04.013"},{"key":"b56","series-title":"Riluzole. Lancet","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(96)03181-9","volume":"348","author":"Wokke J","year":"1996","unstructured":"Wokke J: Riluzole. Lancet 348:795\u2013799, 199610.1016\/S0140-6736(96)03181-9"},{"key":"b57","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neuroscience.2014.01.059","article-title":"Riluzole improves outcome following ischemia-reperfusion injury to the spinal cord by preventing delayed paraplegia","volume":"265","author":"Wu Y","year":"2014","unstructured":"Wu Y, Satkunendrarajah K, Fehlings MG: Riluzole improves outcome following ischemia-reperfusion injury to the spinal cord by preventing delayed paraplegia. Neuroscience 265:302\u2013312, 201410.1016\/j.neuroscience.2014.01.05924508749"},{"key":"b58","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1089\/neu.2012.2622","article-title":"Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury","volume":"30","author":"Wu Y","year":"2013","unstructured":"Wu Y, Satkunendrarajah K, Teng Y, Chow DS, Buttigieg J, Fehlings MG: Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury. J Neurotrauma 30:441\u2013452, 201310.1089\/neu.2012.2622"},{"key":"b1","series-title":"J Clin Neurosci","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jocn.2006.03.023","article-title":"Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury","volume":"14","author":"Ates O","year":"2007","unstructured":"Ates O, Cayli SR, Gurses I, Turkoz Y, Tarim O, Cakir CO, : Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury. J Clin Neurosci 14:658\u2013665, 200710.1016\/j.jocn.2006.03.02317532502"},{"key":"b2","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0006-8993(00)02430-6","article-title":"Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes","volume":"871","author":"Azbill RD","year":"2000","unstructured":"Azbill RD, Mu X, Springer JE: Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res 871:175\u2013180, 20001089928410.1016\/S0006-8993(00)02430-6"},{"key":"b3","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0006-8993(94)01410-J","article-title":"Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat","volume":"672","author":"Bartholdi D","year":"1995","unstructured":"Bartholdi D, Schwab ME: Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res 672:177\u2013186, 199510.1016\/0006-8993(94)01410-J7749740"},{"key":"b4","series-title":"CNS Neurosci Ther","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1755-5949.2009.00116.x","article-title":"A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?","volume":"17","author":"Bellingham MC","year":"2011","unstructured":"Bellingham MC: A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci Ther 17:4\u201331, 201110.1111\/j.1755-5949.2009.00116.x20236142"},{"key":"b5","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nm.4061","article-title":"Cleavage of Na+ channels by calpain increases persistent Na+ current and promotes spasticity after spinal cord injury","volume":"22","author":"Brocard C","year":"2016","unstructured":"Brocard C, Plantier V, Boulenguez P, Liabeuf S, Bouhadfane M, Viallat-Lieutaud A, : Cleavage of Na+ channels by calpain increases persistent Na+ current and promotes spasticity after spinal cord injury. Nat Med 22:404\u2013411, 201610.1038\/nm.406126974309"},{"key":"b6","series-title":"World Neurosurg","first-page":"e247","article-title":"Effect of riluzole on spinal cord regeneration with hemisection method before injury","volume":"114","author":"Caglar YS","year":"2018","unstructured":"Caglar YS, Demirel A, Dogan I, Huseynov R, Eroglu U, Ozgural O, : Effect of riluzole on spinal cord regeneration with hemisection method before injury. World Neurosurg 114:e247\u2013e253, 2018"},{"key":"b7","series-title":"Ulus Travma Acil Cerrahi Derg","first-page":"452","article-title":"Combined and individual use of pancaspase inhibitor Q-VD-OPh and NMDA receptor antagonist riluzole in experimental spinal cord injury","volume":"23","author":"Can H","year":"2017","unstructured":"Can H, Aydoseli A, G\u00f6mleksiz C, G\u00f6ker B, Altunrende ME, Dolgun M, : Combined and individual use of pancaspase inhibitor Q-VD-OPh and NMDA receptor antagonist riluzole in experimental spinal cord injury. Ulus Travma Acil Cerrahi Derg 23:452\u2013458, 201729115658"},{"key":"b8","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.apmr.2004.03.016","article-title":"Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis","volume":"85","author":"Cardenas DD","year":"2004","unstructured":"Cardenas DD, Hoffman JM, Kirshblum S, McKinley W: Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Arch Phys Med Rehabil 85:1757\u20131763, 20041552097010.1016\/j.apmr.2004.03.016"},{"key":"b9","series-title":"Curr Med Chem","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.2174\/092986710791163939","article-title":"Riluzole, neuroprotection and amyotrophic lateral sclerosis","volume":"17","author":"Cheah BC","unstructured":"Cheah BC, Vucic S, Krishnan AV, Kiernan MC: Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 17:1942\u2013199, 201010.2174\/09298671079116393920377511"},{"issue":"1 Suppl","key":"b10","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3171\/2012.5.AOSPINE12112","article-title":"Pharmacology of riluzole in acute spinal cord injury","volume":"17","author":"Chow DS","year":"2012","unstructured":"Chow DS, Teng Y, Toups EG, Aarabi B, Harrop JS, Shaffrey CI, : Pharmacology of riluzole in acute spinal cord injury. J Neurosurg Spine 17 (1 Suppl):129\u2013140, 20122298537910.3171\/2012.5.AOSPINE12112"},{"key":"b11","series-title":"Neuroscientist","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1073858412444932","article-title":"Riluzole: what it does to spinal and brainstem neurons and how it does it","volume":"19","author":"Cifra A","year":"2013","unstructured":"Cifra A, Mazzone GL, Nistri A: Riluzole: what it does to spinal and brainstem neurons and how it does it. Neuroscientist 19:137\u2013144, 201310.1177\/107385841244493222596264"},{"key":"b12","series-title":"Nat Rev Neurosci","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrn3053","article-title":"Repertoire of microglial and macrophage responses after spinal cord injury","volume":"12","author":"David S","year":"2011","unstructured":"David S, Kroner A: Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12:388\u2013399, 201110.1038\/nrn305321673720"},{"key":"b13","series-title":"Top Spinal Cord Inj Rehabil","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1310\/sci1604-1","article-title":"Costs of care following spinal cord injury","volume":"16","author":"DeVivo MJ","year":"2011","unstructured":"DeVivo MJ, Chen Y, Mennemeyer ST, Deutsch A: Costs of care following spinal cord injury. Top Spinal Cord Inj Rehabil 16:1\u20139, 201110.1310\/sci1604-1"},{"issue":"6 Suppl 4","key":"b14","series-title":"Neurology","first-page":"S233","article-title":"The pharmacology and mechanism of action of riluzole","volume":"47","author":"Doble A","year":"1996","unstructured":"Doble A: The pharmacology and mechanism of action of riluzole. Neurology 47 (6 Suppl 4):S233\u2013S241, 1996"},{"key":"b15","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/neu.2012.2587","article-title":"The dual cyclooxygenase\/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord","volume":"30","author":"Dulin JN","year":"2013","unstructured":"Dulin JN, Moore ML, Grill RJ: The dual cyclooxygenase\/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord. J Neurotrauma 30:211\u2013226, 201310.1089\/neu.2012.258722947335"},{"key":"b16","series-title":"Clin Neuropharmacol","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00002826-200109000-00002","article-title":"Acute spinal cord injury, part I: pathophysiologic mechanisms","volume":"24","author":"Dumont RJ","year":"2001","unstructured":"Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, : Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 24:254\u2013264, 20011158611010.1097\/00002826-200109000-00002"},{"key":"b17","series-title":"J Clin Neurosci","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jocn.2017.08.032","article-title":"Riluzole-induced recurrent pancreatitis","volume":"45","author":"Falc\u00e3o de Campos C","year":"2017","unstructured":"Falc\u00e3o de Campos C, de Carvalho M: Riluzole-induced recurrent pancreatitis. J Clin Neurosci 45:153\u2013154, 201710.1016\/j.jocn.2017.08.032"},{"key":"b18","series-title":"Spinal Cord","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sc.2015.95","article-title":"Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial","volume":"54","author":"Fehlings MG","year":"2016","unstructured":"Fehlings MG, Nakashima H, Nagoshi N, Chow DSL, Grossman RG, Kopjar B: Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial. Spinal Cord 54:8\u201315, 201610.1038\/sc.2015.9526099215"},{"issue":"1 Suppl","key":"b19","series-title":"J Neurosurg Spine","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3171\/2012.4.AOSPINE1259","article-title":"Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial","volume":"17","author":"Fehlings MG","year":"2012","unstructured":"Fehlings MG, Wilson JR, Frankowski RF, Toups EG, Aarabi B, Harrop JS, : Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial. J Neurosurg Spine 17 (1 Suppl):151\u2013156, 20122298538110.3171\/2012.4.AOSPINE1259"},{"key":"b20","series-title":"J Spinal Cord Med","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/10790268.2007.11754581","article-title":"Health care costs for patients with chronic spinal cord injury in the Veterans Health Administration","volume":"30","author":"French DD","year":"2007","unstructured":"French DD, Campbell RR, Sabharwal S, Nelson AL, Palacios PA, Gavin-Dreschnack D: Health care costs for patients with chronic spinal cord injury in the Veterans Health Administration. J Spinal Cord Med 30:477\u2013481, 20071809256410.1080\/10790268.2007.11754581"},{"key":"b21","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1089\/neu.2016.4754","article-title":"Delayed spinal cord-brachial plexus reconnection after C7 ventral root avulsion: the effect of reinnervating motoneurons rescued by riluzole treatment","volume":"34","author":"Gloviczki B","year":"2017","unstructured":"Gloviczki B, T\u00f6r\u00f6k DG, M\u00e1rton G, G\u00e1l L, Bodzay T, Pint\u00e9r S, : Delayed spinal cord-brachial plexus reconnection after C7 ventral root avulsion: the effect of reinnervating motoneurons rescued by riluzole treatment. J Neurotrauma 34:2364\u20132374, 20172865748710.1089\/neu.2016.4754"},{"key":"b22","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/neu.2013.2969","article-title":"A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury","volume":"31","author":"Grossman RG","year":"2014","unstructured":"Grossman RG, Fehlings MG, Frankowski RF, Burau KD, Chow DS, Tator C, : A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J Neurotrauma 31:239\u2013255, 201410.1089\/neu.2013.296923859435"},{"issue":"Pt B","key":"b23","series-title":"Int J Dev Neurosci","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijdevneu.2015.08.007","article-title":"Evaluation of the effects of riluzole on adult spinal cord-derived neural stem\/progenitor cells in vitro and in vivo","volume":"47","author":"Hachem LD","year":"2015","unstructured":"Hachem LD, Mothe AJ, Tator CH: Evaluation of the effects of riluzole on adult spinal cord-derived neural stem\/progenitor cells in vitro and in vivo. Int J Dev Neurosci 47 (Pt B):140\u2013146, 20152639095410.1016\/j.ijdevneu.2015.08.007"},{"key":"b24","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/neu.2010.1539","article-title":"Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain","volume":"28","author":"Hama A","year":"2011","unstructured":"Hama A, Sagen J: Antinociceptive effect of riluzole in rats with neuropathic spinal cord injury pain. J Neurotrauma 28:127\u2013134, 201110.1089\/neu.2010.153920954888"},{"key":"b25","series-title":"J Neurophysiol","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1152\/jn.00335.2005","article-title":"Persistent sodium currents and repetitive firing in motoneurons of the sacrocaudal spinal cord of adult rats","volume":"96","author":"Harvey PJ","year":"2006","unstructured":"Harvey PJ, Li Y, Li X, Bennett DJ: Persistent sodium currents and repetitive firing in motoneurons of the sacrocaudal spinal cord of adult rats. J Neurophysiol 96:1141\u20131157, 20061628220610.1152\/jn.00335.2005"},{"key":"b26","series-title":"Degener Neurol Neuromuscul Dis","first-page":"61","article-title":"Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis","volume":"7","author":"Hinchcliffe M","year":"2017","unstructured":"Hinchcliffe M, Smith A: Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis. Degener Neurol Neuromuscul Dis 7:61\u201370, 201730050378"},{"key":"b27","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1089\/neu.2015.3892","article-title":"A direct comparison of three clinically relevant treatments in a rat model of cervical spinal cord injury","volume":"32","author":"Hosier H","year":"2015","unstructured":"Hosier H, Peterson D, Tsymbalyuk O, Keledjian K, Smith BR, Ivanova S, : A direct comparison of three clinically relevant treatments in a rat model of cervical spinal cord injury. J Neurotrauma 32:1633\u20131644, 201510.1089\/neu.2015.3892"},{"key":"b28","series-title":"Spinal Cord","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/sj.sc.3101670","article-title":"Neuropathology: the foundation for new treatments in spinal cord injury","volume":"42","author":"Kakulas BA","year":"2004","unstructured":"Kakulas BA: Neuropathology: the foundation for new treatments in spinal cord injury. Spinal Cord 42:549\u2013563, 20041534613110.1038\/sj.sc.3101670"},{"key":"b29","series-title":"FASEB J","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1096\/fj.02-0143fje","article-title":"Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus","volume":"16","author":"Katoh-Semba R","year":"2002","unstructured":"Katoh-Semba R, Asano T, Ueda H, Morishita R, Takeuchi IK, Inaguma Y, : Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus. FASEB J 16:1328\u20131330, 200210.1096\/fj.02-0143fje12154010"},{"key":"b30","series-title":"Neurosci Lett","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neulet.2009.03.016","article-title":"Effectiveness of riluzole in suppressing spasticity in the spinal cord injured rat","volume":"455","author":"Kitzman PH","year":"2009","unstructured":"Kitzman PH: Effectiveness of riluzole in suppressing spasticity in the spinal cord injured rat. Neurosci Lett 455:150\u2013153, 200910.1016\/j.neulet.2009.03.01619368865"},{"key":"b31","series-title":"J Vasc Surg","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1067\/mva.2000.105960","article-title":"Prevention of ischemic spinal cord injury: comparative effects of magnesium sulfate and riluzole","volume":"32","author":"Lang-Lazdunski L","year":"2000","unstructured":"Lang-Lazdunski L, Heurteaux C, Dupont H, Widmann C, Lazdunski M: Prevention of ischemic spinal cord injury: comparative effects of magnesium sulfate and riluzole. J Vasc Surg 32:179\u2013189, 20001087622110.1067\/mva.2000.105960"},{"key":"b32","series-title":"Eur J Cardiothorac Surg","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1010-7940(00)00430-9","article-title":"Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole","volume":"18","author":"Lang-Lazdunski L","year":"2000","unstructured":"Lang-Lazdunski L, Heurteaux C, Mignon A, Mantz J, Widmann C, Desmonts J, : Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole. Eur J Cardiothorac Surg 18:174\u2013181, 200010.1016\/S1010-7940(00)00430-910925226"},{"key":"b33","series-title":"Anesthesiology","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00000542-200011000-00025","article-title":"Neuroprotective effects of riluzole and ketamine during transient spinal cord ischemia in the rabbit","volume":"93","author":"Lips J","year":"2000","unstructured":"Lips J, de Haan P, Bodewits P, Vanicky I, Dzoljic M, Jacobs MJ, : Neuroprotective effects of riluzole and ketamine during transient spinal cord ischemia in the rabbit. Anesthesiology 93:1303\u20131311, 200010.1097\/00000542-200011000-0002511046220"},{"key":"b34","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.spinee.2017.10.067","article-title":"Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats","volume":"18","author":"Martins BC","year":"2018","unstructured":"Martins BC, Torres BBJ, de Oliveira KM, Lavor MS, Os\u00f3rio CM, Fukushima FB, : Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats. Spine J 18:532\u2013539, 20182915525410.1016\/j.spinee.2017.10.067"},{"key":"b35","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainres.2005.01.024","article-title":"The effect of glutamate receptor blockers on glutamate release following spinal cord injury. Lack of evidence for an ongoing feedback cascade of damage \u2192 glutamate release \u2192 damage \u2192 glutamate release \u2192 etc","volume":"1038","author":"McAdoo DJ","year":"2005","unstructured":"McAdoo DJ, Hughes MG, Nie L, Shah B, Clifton C, Fullwood S, : The effect of glutamate receptor blockers on glutamate release following spinal cord injury. Lack of evidence for an ongoing feedback cascade of damage \u2192 glutamate release \u2192 damage \u2192 glutamate release \u2192 etc. Brain Res 1038:92\u201399, 200510.1016\/j.brainres.2005.01.02415748877"},{"key":"b36","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0140-6736(02)07603-1","article-title":"Spinal-cord injury","volume":"359","author":"McDonald JW","year":"2002","unstructured":"McDonald JW, Sadowsky C: Spinal-cord injury. Lancet 359:417\u2013425, 20021184453210.1016\/S0140-6736(02)07603-1"},{"key":"b37","series-title":"Asian J Neurosurg","first-page":"656","article-title":"Riluzole can improve sensory and motor function in patients with acute spinal cord injury","volume":"13","author":"Meshkini A","year":"2018","unstructured":"Meshkini A, Salehpour F, Aghazadeh J, Mirzaei F, Naseri Alavi SA: Riluzole can improve sensory and motor function in patients with acute spinal cord injury. Asian J Neurosurg 13:656\u2013659, 201830283521"},{"key":"b38","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1089\/neu.2000.17.773","article-title":"Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury","volume":"17","author":"Mu X","year":"2000","unstructured":"Mu X, Azbill RD, Springer JE: Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury. J Neurotrauma 17:773\u2013780, 20001101181710.1089\/neu.2000.17.773"},{"key":"b39","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0006-8993(00)02402-1","article-title":"Riluzole improves measures of oxidative stress following traumatic spinal cord injury","volume":"870","author":"Mu X","year":"2000","unstructured":"Mu X, Azbill RD, Springer JE: Riluzole improves measures of oxidative stress following traumatic spinal cord injury. Brain Res 870:66\u201372, 200010.1016\/S0006-8993(00)02402-110869502"},{"key":"b40","series-title":"J Spinal Cord Med","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1179\/1079026812Z.00000000063","article-title":"Spinal cord injury facts and figures at a glance","volume":"35","author":"National Spinal Cord Injury Statistical Center","year":"2012","unstructured":"National Spinal Cord Injury Statistical Center: Spinal cord injury facts and figures at a glance. J Spinal Cord Med 35:197\u2013198, 201210.1179\/1079026812Z.00000000063"},{"key":"b41","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuroscience.2006.09.046","article-title":"Delayed riluzole treatment is able to rescue injured rat spinal motoneurons","volume":"144","author":"N\u00f3gr\u00e1di A","year":"2007","unstructured":"N\u00f3gr\u00e1di A, Szab\u00f3 A, Pint\u00e9r S, Vrbov\u00e1 G: Delayed riluzole treatment is able to rescue injured rat spinal motoneurons. Neuroscience 144:431\u2013438, 20071708453710.1016\/j.neuroscience.2006.09.046"},{"key":"b42","series-title":"Neurobiol Dis","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1006\/nbdi.2000.0297","article-title":"A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C","volume":"7","author":"Noh KM","year":"2000","unstructured":"Noh KM, Hwang JY, Shin HC, Koh JY: A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiol Dis 7:375\u2013383, 20001096460810.1006\/nbdi.2000.0297"},{"key":"b43","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1089\/0897715041269641","article-title":"The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration","volume":"21","author":"Park E","year":"2004","unstructured":"Park E, Velumian AA, Fehlings MG: The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21:754\u2013774, 200410.1089\/089771504126964115253803"},{"key":"b44","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1089\/neu.2010.1445","article-title":"Increased survival and reinnervation of cervical motoneurons by riluzole after avulsion of the C7 ventral root","volume":"27","author":"Pint\u00e9r S","year":"2010","unstructured":"Pint\u00e9r S, Gloviczki B, Szab\u00f3 A, M\u00e1rton G, N\u00f3gr\u00e1di A: Increased survival and reinnervation of cervical motoneurons by riluzole after avulsion of the C7 ventral root. J Neurotrauma 27:2273\u20132282, 20102093969510.1089\/neu.2010.1445"},{"issue":"5","key":"b45","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/FOC.2008.25.11.E2","article-title":"Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon","volume":"25","author":"Rowland JW","year":"2008","unstructured":"Rowland JW, Hawryluk GW, Kwon B, Fehlings MG: Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 25(5):E2, 200810.3171\/FOC.2008.25.11.E218980476"},{"key":"b46","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.neuroscience.2012.06.064","article-title":"A study of the potential neuroprotective effect of riluzole on locomotor networks of the neonatal rat spinal cord in vitro damaged by excitotoxicity","volume":"222","author":"S\u00e1mano C","year":"2012","unstructured":"S\u00e1mano C, Nasrabady SE, Nistri A: A study of the potential neuroprotective effect of riluzole on locomotor networks of the neonatal rat spinal cord in vitro damaged by excitotoxicity. Neuroscience 222:356\u2013365, 201210.1016\/j.neuroscience.2012.06.06422771622"},{"key":"b47","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.expneurol.2015.09.011","article-title":"Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection","volume":"276","author":"Satkunendrarajah K","year":"2016","unstructured":"Satkunendrarajah K, Nassiri F, Karadimas SK, Lip A, Yao G, Fehlings MG: Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection. Exp Neurol 276:59\u201371, 20162639420210.1016\/j.expneurol.2015.09.011"},{"issue":"2 Suppl","key":"b48","series-title":"J Neurosurg","first-page":"245","article-title":"Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole","volume":"94","author":"Schwartz G","year":"2001","unstructured":"Schwartz G, Fehlings MG: Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole. J Neurosurg 94 (2 Suppl):245\u2013256, 200111302627"},{"key":"b49","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1089\/neu.2017.5494","article-title":"Prophylactic riluzole attenuates oxidative stress damage in spinal cord distraction","volume":"35","author":"Shimizu EN","year":"2018","unstructured":"Shimizu EN, Seifert JL, Johnson KJ, Romero-Ortega MI: Prophylactic riluzole attenuates oxidative stress damage in spinal cord distraction. J Neurotrauma 35:1319\u20131328, 20182929564710.1089\/neu.2017.5494"},{"key":"b50","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.expneurol.2011.11.044","article-title":"Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury","volume":"233","author":"Simard JM","year":"2012","unstructured":"Simard JM, Tsymbalyuk O, Keledjian K, Ivanov A, Ivanova S, Gerzanich V: Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury. Exp Neurol 233:566\u2013574, 201210.1016\/j.expneurol.2011.11.044"},{"key":"b51","series-title":"J Neurochem","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1046\/j.1471-4159.1997.69041592.x","article-title":"Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment","volume":"69","author":"Springer JE","year":"1997","unstructured":"Springer JE, Azbill RD, Kennedy SE, George J, Geddes JW: Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J Neurochem 69:1592\u20131600, 1997932628810.1046\/j.1471-4159.1997.69041592.x"},{"key":"b52","series-title":"Orthopedics","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3928\/01477447-20080301-39","article-title":"Hemodynamic management after spinal cord injury","volume":"31","author":"Stratman RC","year":"2008","unstructured":"Stratman RC, Wiesner AM, Smith KM, Cook AM: Hemodynamic management after spinal cord injury. Orthopedics 31:252\u2013255, 200810.3928\/01477447-20080301-3918351045"},{"key":"b53","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1523\/JNEUROSCI.23-07-02899.2003","article-title":"Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats","volume":"23","author":"Sung B","year":"2003","unstructured":"Sung B, Lim G, Mao J: Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci 23:2899\u20132910, 200310.1523\/JNEUROSCI.23-07-02899.200312684477"},{"key":"b54","series-title":"J Neurophysiol","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1152\/jn.00570.2010","article-title":"Riluzole decreases flexion withdrawal reflex but not voluntary ankle torque in human chronic spinal cord injury","volume":"105","author":"Theiss RD","year":"2011","unstructured":"Theiss RD, Hornby TG, Rymer WZ, Schmit BD: Riluzole decreases flexion withdrawal reflex but not voluntary ankle torque in human chronic spinal cord injury. J Neurophysiol 105:2781\u20132790, 20112143028010.1152\/jn.00570.2010"},{"key":"b55","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.spinee.2016.04.013","article-title":"Combining neuroprotective agents: effect of riluzole and magnesium in a rat model of thoracic spinal cord injury","volume":"16","author":"Vasconcelos NL","year":"2016","unstructured":"Vasconcelos NL, Gomes ED, Oliveira EP, Silva CJ, Lima R, Sousa N, : Combining neuroprotective agents: effect of riluzole and magnesium in a rat model of thoracic spinal cord injury. Spine J 16:1015\u20131024, 201610.1016\/j.spinee.2016.04.013"},{"key":"b56","series-title":"Riluzole. Lancet","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(96)03181-9","volume":"348","author":"Wokke J","year":"1996","unstructured":"Wokke J: Riluzole. Lancet 348:795\u2013799, 199610.1016\/S0140-6736(96)03181-9"},{"key":"b57","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neuroscience.2014.01.059","article-title":"Riluzole improves outcome following ischemia-reperfusion injury to the spinal cord by preventing delayed paraplegia","volume":"265","author":"Wu Y","year":"2014","unstructured":"Wu Y, Satkunendrarajah K, Fehlings MG: Riluzole improves outcome following ischemia-reperfusion injury to the spinal cord by preventing delayed paraplegia. Neuroscience 265:302\u2013312, 201410.1016\/j.neuroscience.2014.01.05924508749"},{"key":"b58","series-title":"J Neurotrauma","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1089\/neu.2012.2622","article-title":"Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury","volume":"30","author":"Wu Y","year":"2013","unstructured":"Wu Y, Satkunendrarajah K, Teng Y, Chow DS, Buttigieg J, Fehlings MG: Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury. J Neurotrauma 30:441\u2013452, 201310.1089\/neu.2012.2622"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/46\/3\/article-pE6.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/46\/3\/article-pE6.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/46\/3\/article-pE6.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:44:17Z","timestamp":1780130657000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/46\/3\/article-pE6.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":116,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2019.1.focus18596","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}